株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インスリン送達装置の世界市場の将来予測

GLOBAL INSULIN DELIVERY SYSTEM MARKET FORECAST 2017-2025

発行 Inkwood Research 商品コード 563521
出版日 ページ情報 英文 112 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
インスリン送達装置の世界市場の将来予測 GLOBAL INSULIN DELIVERY SYSTEM MARKET FORECAST 2017-2025
出版日: 2017年10月09日 ページ情報: 英文 112 Pages
概要

当レポートでは、世界のインスリン送達装置 (インスリン・デリバリー・システム) 市場の将来展望について分析し、製品の特性や市場の基本構造、主な促進・抑制要因、市場全体および製品別・エンドユーザー別・地域別の市場動向見通し (今後9年間分)、市場の競争状態と求心力、主要企業のプロファイルなどを調査しております。

第1章 分析範囲

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 市場の決定要因

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第5章 市場区分

  • 製品別
    • インスリンシリンジ
    • インスリンポンプ
    • インスリンペン
    • インスリン・ジェットインジェクター
  • エンドユーザー別
    • 在宅治療
    • 病院・クリニック
    • その他

第6章 主要指標

  • ポーターのファイブフォース分析
  • 市場機会マトリックス
  • バリューチェーン分析
  • ベンダー環境

第7章 地域分析

  • 北米 (米国、カナダ)
  • 欧州 (ドイツ、英国、フランスなど)
  • アジア太平洋地域 (中国、インド、オーストラリアなど)
  • ラテンアメリカ
  • 他の国々 (RoW)

第8章 企業プロファイル

目次
Product Code: 10536

KEY FINDINGS:

The Global Insulin Delivery system market was valued at $10963 million in 2016 and is predicted to rise up to $24034 million by 2025, growing at an estimated CAGR of 9.11%. The easy availability of medication and delivery systems, prevailing incidences of type1 diabetes and the shifting focus towards self-management of diabetes can be credited for the market expansion.

MARKET INSIGHTS:

The Global Insulin Delivery system market is segmented on the basis of products and end users. The products are further divided into insulin pumps, insulin syringes, insulin pens, and insulin jet injectors. Of these, Insulin pens are most popular in the market. The end-users for the market include hospitals and clinics, home care and others. Hospitals are the leading end-users for the market since they utilize these delivery systems on a large scale and considerably engage with reimbursement authorities, government organizations and the suppliers for the same.

REGIONAL INSIGHTS:

Geographically, the global Insulin delivery system market is segmented on the basis of five major regions including Asia-Pacific, Europe, North America, Latin America and the rest of the world. The Asia-Pacific region is predicted to be the fastest-growing region for the forecast period with India and China being its major contributor. However, the North American market is anticipated to hold the biggest share by 2025, owing to the rising prevalence of type 1 diabetes and the growing obese and overweight population. The increasing government support is also contributing to propel the market ahead.

COMPETITIVE INSIGHTS:

Becton, Dickinson, and Company operates across Canada, US, Latin America, the Middle East & Africa, Europe, and Asia Pacific. The company provides laboratory equipment and diagnostic products and devices for life science researchers, healthcare institutions, clinical laboratories, and the pharmaceutical industry. Some of the other leading market players include Animas Corporation (Johnson and Johnson), Tandem Diabetes Care, Eli Lilly And Company, Biocon Limited, Insulet Corporation, Novo Nordisk A/S, Medtronic Plc, Sanofi, and Ypsomed Holding Ag.

TABLE OF CONTENTS

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. RISING INCIDENCES OF DIABETES
    • 3.2.2. RISE IN AWARENESS OF THE GLUCOSE MONITORING DEVICES
    • 3.2.3. INSULIN PENS ARE THE LARGEST CONTRIBUTOR OF INSULIN DELIVERY MARKET
    • 3.2.4. HOME CARE IS THE LARGEST INSULIN DELIVERY MARKET END-USER SEGMENT

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. UPSURGE IN TYPE-1 DIABETES
    • 4.1.2. AVAILABILITY OF MEDICATION AND DELIVERY SYSTEMS AT THE ATTACHED PHARMACY STORES
    • 4.1.3. EMPHASIS ON SELF-MANAGEMENT OF DIABETES
  • 4.2. MARKET RESTRAINTS
    • 4.2.1. STRINGENT GOVERNMENT REGULATIONS
    • 4.2.2. DEARTH OF INFORMATION
  • 4.3. MARKET OPPORTUNITIES
    • 4.3.1. SWELLING RESEARCH AND DEVELOPMENT
    • 4.3.2. GROWING DIABETES ASSOCIATED HEALTH EXPENSES
  • 4.4. MARKET CHALLENGES
    • 4.4.1. RISE IN HEALTHCARE EXPENDITURE ON MEDICATION
    • 4.4.2. RISK OF SUBSTITUTES
    • 4.4.3. STRINGENT REIMBURSEMENT PROCEDURES
    • 4.4.4. COMPLICATIONS RELATED TO CERTAIN INSULIN DEVICES

5. MARKET SEGMENTS

  • 5.1. MARKET BY PRODUCT 2017-2025
    • 5.1.1. INSULIN SYRINGES
    • 5.1.2. INSULIN PUMPS
    • 5.1.3. INSULIN PENS
    • 5.1.4. INSULIN JET INJECTORS
  • 5.2. MARKET BY END USER 2017-2025
    • 5.2.1. HOME CARE
    • 5.2.2. HOSPITALS AND CLINICS
    • 5.2.3. OTHER END USERS

6. KEY ANALYTICS

  • 6.1. 5 FORCES ANALYSIS
    • 6.1.1. BARGAINING POWER OF BUYERS
    • 6.1.2. BARGAINING POWER OF SUPPLIERS
    • 6.1.3. THREAT OF NEW ENTRANTS
    • 6.1.4. THREAT OF SUBSTITUTES
    • 6.1.5. COMPETITIVE RIVALRY
  • 6.2. OPPORTUNITY MATRIX
  • 6.3. VALUE CHAIN ANALYSIS
  • 6.4. VENDOR LANDSCAPE

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. U.S
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. GERMANY
    • 7.2.2. THE UK
    • 7.2.3. FRANCE
    • 7.2.4. REST OF EUROPE (ROE)
  • 7.3. ASIA-PACIFIC (APAC)
    • 7.3.1. CHINA
    • 7.3.2. INDIA
    • 7.3.3. AUSTRALIA
    • 7.3.4. REST OF ASIA-PACIFIC (ROAP)
  • 7.4. LATIN AMERICA
  • 7.5. REST OF THE WORLD (ROW)

8. COMPANY PROFILES

  • 8.1. ANIMAS CORPORATION (JOHNSON AND JOHNSON)
  • 8.2. BECTON, DICKINSON, AND COMPANY
  • 8.3. BIOCON LIMITED
  • 8.4. ELI LILLY AND COMPANY
  • 8.5. INSULET CORPORATION
  • 8.6. MEDTRONIC PLC
  • 8.7. NOVO NORDISK A/S
  • 8.8. SANOFI
  • 8.9. TANDEM DIABETES CARE, INC.
  • 8.10. YPSOMED HOLDING AG

TABLE LIST

  • TABLE 1 GLOBAL INSULIN DELIVERY SYSTEMS MARKET, BY GEOGRAPHY 2017-2025 ($ MILLION)
  • TABLE 2 GLOBAL INSULIN DELIVERY SYSTEMS MARKET, BY PRODUCT 2017-2025 ($ MILLION)
  • TABLE 3 GLOBAL INSULIN DELIVERY SYSTEMS MARKET, BY END-USER 2017-2025 ($ MILLION)
  • TABLE 4 GLOBAL INSULIN DELIVERY SYSTEMS MARKET, BY GEOGRAPHY 2017-2025 ($ MILLION)
  • TABLE 5 NORTH AMERICA INSULIN DELIVERY MARKET, BY COUNTRIES 2017-2025 ($ MILLION)
  • TABLE 6 EUROPE INSULIN DELIVERY MARKET, BY COUNTRIES 2017-2025 ($ MILLION)
  • TABLE 7 GERMANY DIABETIC STATISTICS 2015
  • TABLE 8 ASIA-PACIFIC INSULIN DELIVERY MARKET, BY COUNTRIES 2017-2025(US$ MILLION)

FIGURE LIST

  • FIGURE 1 GLOBAL INSULIN DELIVERY SYSTEMS MARKET 2017-2025 ($ MILLION)
  • FIGURE 2 GLOBAL INSULIN SYRINGES MARKET, 2017-2025 ($ MILLION)
  • FIGURE 3 GLOBAL INSULIN PUMPS MARKET, 2017-2025 ($ MILLION)
  • FIGURE 4 FACTORS CONSIDERED FOR MAKING AN IDEAL PEN
  • FIGURE 5 GLOBAL INSULIN PENS MARKET, 2017-2025 ($ MILLION)
  • FIGURE 6 GLOBAL INSULIN JET INJECTORS MARKET, 2017-2025 ($ MILLION)
  • FIGURE 7 GLOBAL HOME CARE MARKET, 2017-2025 ($ MILLION)
  • FIGURE 8 GLOBAL HOSPITALS AND CLINICS MARKET, 2017-2025 ($ MILLION)
  • FIGURE 9 GLOBAL OTHER END USERS MARKET, 2017-2025 ($ MILLION)
  • FIGURE 10 NORTH AMERICA INSULIN DELIVERY MARKET SHARE, BY COUNTRY 2016 & 2025 (%)
  • FIGURE 11 UNITED STATES INSULIN DELIVERY MARKET REVENUE, 2017-2025($ MILLION)
  • FIGURE 12 CANADA INSULIN DELIVERY MARKET REVENUE, 2017-2025 ($ MILLION)
  • FIGURE 13 EUROPE INSULIN DELIVERY MARKET SHARE, BY COUNTRY 2016& 2025 (%)
  • FIGURE 14 GERMANY INSULIN DELIVERY MARKET REVENUE, 2017-2025($ MILLION)
  • FIGURE 15 UNITED KINGDOM INSULIN DELIVERY MARKET REVENUE, 2017-2025($ MILLION)
  • FIGURE 16 FRANCE INSULIN DELIVERY MARKET REVENUE, 2017-2025($ MILLION)
  • FIGURE 17 REST OF EUROPE (ROE) INSULIN DELIVERY MARKET REVENUE, 2017-2025($ MILLION)
  • FIGURE 18 ASIA-PACIFIC INSULIN DELIVERY MARKET REVENUE 2017-2025(US$ MILLION)
  • FIGURE 19 CHINA INSULIN DELIVERY MARKET REVENUE, 2017-2025($ MILLION)
  • FIGURE 20 INDIA INSULIN DELIVERY MARKET REVENUE, 2017-2025($ MILLION)
  • FIGURE 21 AUSTRALIA INSULIN DELIVERY MARKET REVENUE, 2017-2025($ MILLION)
  • FIGURE 22 REST OF ASIA-PACIFIC INSULIN DELIVERY MARKET REVENUE, 2017-2025($ MILLION)
  • FIGURE 23 LATIN AMERICA INSULIN DELIVERY MARKET REVENUE, 2017-2025($ MILLION)
  • FIGURE 24 REST OF WORLD INSULIN DELIVERY MARKET REVENUE, 2017-2025($ MILLION)
Back to Top